Warner, Kaine, and McClellan Celebrate $16 Million in Federal Funding for Richmond-Petersburg Pharmaceutical Manufacturing Hub

About Committees and Caucuses Our District Votes and Legislation Contact Email Me Newsletter Subscribe Office Locations Request an Appearance Website Problem Share Your Story Media 2025 in Review 118th Congress in Review In the News Media Kit Newsletters Press Releases Issues Agriculture Armed Services Civil Rights Communications And Technology Congress Economy Education Energy/Environment Health Immigration National Security Repro VA-04 Veterans What Issues Matter To You? Services Art Competition Black History Month Essay Contest Casework Tips! Commendations and Greetings Congressional App Challenge Flags Grant Applicants Help With a Federal Agency Internships Service Academy Nominations Tours and Tickets Valentines for Vets Youth Advisory Council Resources Appropriations Requests Government Shutdown Resources & FAQs Know Your Breastfeeding Rights Know Your Federal Employee Rights Know your Immigration Rights Know Your Reproductive Rights Follow Follow Follow Follow Follow Follow Warner, Kaine, and McClellan Celebrate $16 Million in Federal Funding for Richmond-Petersburg Pharmaceutical Manufacturing Hub July 20, 2026 | Congress , Economy , Health , Press Releases , VA-04 Washington, D.C – Today, U.S. Senators Mark R. Warner and Tim Kaine (both D-VA) and U.S. Representative Jennifer McClellan (D-VA-04) celebrated $16 million in federal funding for the Virginia Advanced Pharma Manufacturing (APM) and R&D Cluster in the Richmond-Petersburg region. The cluster is led by the Virginia Biotechnology Research Partnership Authority. The funding, awarded through the U.S. Economic Development Administration’s (EDA) Regional Technology and Innovation Hubs Program, will help the cluster fully establish a domestic manufacturing pathway for essential medicines and advance U.S. national security and economic competitiveness. The members wrote letters in support of the funding. “For years, Virginia and the Virginia Advanced Pharma Manufacturing Cluster have been leading the charge in establishing our country’s dominance in the production of critical medicines,” said Warner. “These federal dollars will help cement the Commonwealth’s position as a national leader in advanced pharmaceutical manufacturing while creating good-paying jobs in the Petersburg region, strengthening our economy, reducing our reliance on foreign supply chains, and protecting our national security.” “I’m thrilled that $16 million is headed to the Virginia Advanced Pharma Manufacturing Cluster to support the domestic manufacturing of critical medicines, boost our supply chains, and grow our regional economy,” said Kaine. “When I was on the Richmond City Council, I helped form the Virginia Biotechnology Research Partnership Authority, and I’m immensely proud of what we’ve done together to turn it into a thriving domestic manufacturing hub and economic engine in the region. I look forward to the continued partnership.” “To remain competitive on the global stage, we must continue to invest in domestic manufacturing for life-saving medicines that create jobs, support regional growth and offer reliable access to medications for patients in need,” said McClellan . “This grant funding will do all that and more by supporting the Virginia Advanced Pharma Manufacturing Cluster in its core mission to create a sustainable and cutting-edge manufacturing hub in the Richmond-Petersburg region. I thank Senators Warner and Kaine for their partnership and look forward to the developments this will bring to Virginia’s Fourth District.” Warner, Kaine, and McClellan have long supported the APM cluster in Richmond-Petersburg and have supported policies to strengthen domestic manufacturing of critical medicines. In 2023, the APM cluster was designated as a Tech Hub under the CHIPS and Science Act for its innovative work in advanced pharmaceutical manufacturing. In September 2022, the senators helped secure $52.9 million from the American Rescue Plan Act for the cluster. In January 2025, the senators announced $3.9 million from the American Rescue Plan Act to expand regional workforce training programs that support the APM cluster. In August 2024, Kaine toured Phlow Corp., a pharmaceutical manufacturing plant in the Virginia APM cluster. In April 2022, Kaine visited the cluster to learn more about its efforts to streamline prescription drug manufacturing. Kaine helped form and grow the Virginia Biotechnology Research Partnership Authority while he was on Richmond City Council, served on the Authority’s board as Mayor of Richmond, and appointed its board members as Governor of Virginia. Office Locations Washington D.C. Office 1628 Longworth House Office Building Washington, DC 20515 Phone: (202) 225-6365 Richmond District Office 11 S. 12th Street Suite 401 Richmond, VA 23219 Phone: (804) 486-1840 Brunswick Satellite Office 100 Athletic Field Road Lawrenceville, VA 23868 Phone: (804) 690-5809 10am – 4:30pm — every Thursday, or by appointment Mailing Address: P.O. Box 211 Lawren